Editorial to the “Safety and Efficacy of Direct Oral Anticoagulants Compared to Vitamin K Antagonist Post Percutaneous Coronary Artery Interventions in Patients With Atrial Fibrillation: A Systematic Revie and Meta‐analysis”

Journal of Arrhythmia - Netherlands
doi 10.1002/joa3.12317
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Comparison Between Long-Term Clinical Outcomes of Vitamin K Antagonist and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Circulation Journal
MedicineCardiovascular MedicineCardiology
2018English

Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

Journal of Clinical Trials in Cardiology
2017English

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients With Renal Impairment

Pharmacy
2020English

Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis of the Literature

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study

British Medical Journal
Medicine
2016English

Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants

Journal of Medical Economics
Health Policy
2019English

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Real-World Adherence to Oral Anticoagulants in Atrial Fibrillation Patients: A Study Protocol for a Systematic Review and Meta-Analysis

BMJ Open
Medicine
2018English

Safety and Efficacy of Triple Antithrombotic Therapy With Dabigatran Versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy